Cyclobenzaprine hydrochloride is a generic prescription skeletal muscle relaxant used to relieve painful muscle spasms due to musculoskeletal conditions. Cyclobenzaprine relieves muscle spasms and muscle pain by acting directly on the central nervous system (CNS), reducing muscle hyperactivity. Cyclobenzaprine is a tablet that can be taken up to three times a day for up to three weeks. It is also available as an oral extended-release capsules that only require a single daily dose.
RELATED: Learn more about cyclobenzaprine
Check our best Cyclobenzaprine prices
Detailed cyclobenzaprine dosage chart for adults |
|||
|---|---|---|---|
| Indication | Starting dose | Standard dose | Maximum dose |
| Painful muscle spasms | 5 mg tablet 3 times daily OR 15 mg capsule once daily | 5–10 mg tablet 3 times daily OR 15–30 mg capsule once daily | 30 mg/day |
| Fibromyalgia (off-label) | 5–10 mg tablet at bedtime | 5–40 mg tablets taken at bedtime or in divided doses | 20-40 mg/day |
The dosages listed are general guidelines, especially around maximum dosage; your healthcare provider may adjust your dose based on individual health factors.
For painful localized muscle spasms due to musculoskeletal conditions, cyclobenzaprine is part of a larger treatment regimen that also includes rest and physical therapy. The FDA has approved its use in adults and adolescents 15 years of age and older. It’s a short-term therapy, meant only to be used for short periods of two to three weeks.
Although cyclobenzaprine is only approved to provide relief of muscle spasms, healthcare providers sometimes prescribe it off-label to relieve sleep disturbances due to fibromyalgia. Dosing is typically done at bedtime to assist with sleep, but very large daily doses can be divided throughout the day. Because cyclobenzaprine is prescribed off-label for fibromyalgia, dosing and treatment duration have not been standardized. The maximum daily dosage for fibromyalgia is 40 mg per day according to some studies, but lower doses like 20 mg/day are preferable.
Because cyclobenzaprine is broken down by the liver, people with impaired liver function may become more sedated when taking cyclobenzaprine than other patients. As a result, healthcare providers always start with the lowest dose of short-acting cyclobenzaprine, 5 mg daily in those with mild liver disease, and the medication is best avoided in patients with moderate to severe liver disease. The dose can be slowly increased if necessary while monitoring carefully. Extended-release cyclobenzaprine is avoided in elderly patients and in those with liver impairment.
No dose adjustment is indicated in those with altered kidney function, but caution is recommended due to lack of safety and efficacy data.
The most common side effects are drowsiness, dizziness, confusion, and dry mouth. Because of the risk for serious side effects, the FDA has approved cyclobenzaprine only for short-term use.
The use of cyclobenzaprine is contraindicated in people with:
Known allergies to the drug
Heart rhythm problems
Heart block
Overactive thyroid
Recently had a heart attack
Immediately stop using cyclobenzaprine and contact the prescriber or get medical attention if you experience symptoms of an allergic reaction or irregular heartbeat.
The most important safety concern is that cyclobenzaprine, as a CNS depressant, causes sedation, somnolence, dizziness, and confusion. Do not drive or engage in any other risky activities until you know how doses affect you. Do not drink alcohol on the days you take cyclobenzaprine.
Precautions are needed when cyclobenzaprine is used in people with:
A history of urinary retention
High eye pressure
Cyclobenzaprine is not considered absolutely contraindicated in pregnancy, but its safety is not fully established. Use should be reserved for situations where benefits clearly outweigh risks, with preference for short-term, low-dose therapy, and close monitoring for adverse effects is recommended.
Cyclobenzaprine is excreted into human milk in low concentrations, with a calculated relative infant dose (RID) of approximately 0.5% of the maternal weight-adjusted dose—well below the commonly accepted threshold of concern (10%) for most medications during lactation. However, cyclobenzaprine possesses sedative properties, and the medical literature recommends regular clinical assessment of the infant for signs of sedation, poor feeding, or other adverse effects if maternal use is necessary.
Cyclobenzaprine has several drug interactions that can cause serious complications. Make sure the prescriber knows about all medications being used before starting this drug. Here are the most important:
Monoamine oxidase inhibitors (MAOIs)
MAO inhibitors are contraindicated for use with cyclobenzaprine. They cannot be used within 14 days before or after a cyclobenzaprine dose.
Drugs that also cause sedation
Narcotic pain relievers, sedatives (benzodiazepines), selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, sleeping pills, barbiturates, and alcohol. Concomitant use of these drugs can worsen the sedative effects of cyclobenzaprine.
Drugs that work like cyclobenzaprine, called serotonergic drugs
Taking more than one drug that raises serotonin levels can cause serotonin syndrome, a potentially severe condition caused by too much serotonin in the brain. These include antidepressants, other drugs that treat mental health issues, opioids, migraine medications, and others.
The health care provider is not required to gradually reduce the dose when it’s time to stop, but some people may experience adverse effects, including nausea, vomiting, sweating, and insomnia. To forestall these problems, some clinicians may choose to taper the dose at discontinuation, but there is no set tapering schedule.
Cyclobenzaprine is taken by mouth as either a tablet or a capsule. Follow all the prescriber’s directions, and do not take more than the recommended dosage.
This medicine is not for long-term use.
Take this medicine at the same time each day.
Doses can be taken with or without food.
If tablets or capsules cause stomach problems, try taking the dose with food.
Tablets can be taken three times a day.
Swallow the cyclobenzaprine oral tablet whole with a glass of water.
Cyclobenzaprine extended-release capsules are taken once per day at the same time each day.
Swallow the oral extended-release capsule whole. Do not crush, break, or chew the capsules or granules inside the capsule.
If you cannot swallow the capsule whole:
Open the capsule and sprinkle the contents over one tablespoon of applesauce. Do not use any food other than applesauce.
Swallow the mixture immediately without chewing.
Rinse your mouth to ensure all of the medicine has been swallowed.
Do not save any of the mixture to use later.
Cyclobenzaprine tablets or capsules should be stored at room temperature in a tightly closed container away from light and out of the reach of children.
15 mg/day, either 5 mg cyclobenzaprine immediate release (IR) taken three times daily or 15 mg cyclobenzaprine extended release (ER) taken once daily.
Take only three doses of immediate-release cyclobenzaprine or one dose of extended-release cyclobenzaprine in a 24-hour period.
Elderly patients are typically started on a lower dose because of the greater risk of side effects, but the maximum dosage can be the same as it is for younger adults. Although caution is recommended, clinicians should look at other medications to avoid drug interactions. Clinicians avoid prescribing extended-release cyclobenzaprine to older adults.
The doctor may change the initial cyclobenzaprine dose if the lower dose is inadequate for controlling pain. There are only two dosages for both immediate-release and extended-release cyclobenzaprine: 15 mg/day or 30 mg/day. Treatment only lasts two or three weeks.
Take a dose as soon as you remember. If it is almost time for the next dose, wait until then and take that dose. Do not take extra medicine to make up for a missed dose.
Cyclobenzaprine, StatPearls
Cyclobenzaprine capsule prescribing information, DailyMed (NIH National Library of Medicine)
Cyclobenzaprine hydrochloride tablet prescribing information, DailyMed (NIH National Library of Medicine)
Flexeril drug summary, Prescriber’s Digital Reference (PDR)
Muscle relaxants (toxicity), Merck Veterinary Manual
Symptoms of withdrawal from tricyclic antidepressants, Canadian Medical Association Journal
Chad Shaffer, MD, earned his medical doctorate from Penn State University and completed a combined Internal Medicine and Pediatrics residency at the University of Pittsburgh Medical Center and Children’s Hospital of Pittsburgh. He is board certified by the American Board of Internal Medicine and the American Board of Pediatrics. He has provided full-service primary care to all ages for over 15 years, building a practice from start up to over 3,000 patients. His passion is educating patients on their health and treatment, so they can make well-informed decisions.
...SingleCare es un servicio de descuentos para medicamentos recetados que ofrece cupones gratuitos para miles de medicamentos. Puedes usarlo aun si tienes seguro, Medicare, Medicaid o no, pero no se puede combinar con el seguro.
SingleCare ofrece transparencia al mostrar los precios de medicamentos para que puedas comparar descuentos en farmacias cerca de ti. Visita singlecare.com para encontrar descuentos en medicamentos, información útil sobre tu receta médica y recursos que te ayudan a tomar decisiones informadas sobre tu salud.
Los ahorros en recetas varían según la receta médica y la farmacia, y pueden alcanzar hasta un 80% de descuento sobre el precio en efectivo. Este es un plan de descuento de recetas médicas. NO es un seguro ni un plan de medicamentos de Medicare. El rango de descuentos para las recetas médicas que se brindan bajo este plan, dependerá de la receta y la farmacia donde se adquiera la receta y puede otorgarse hasta un 80% de descuento sobre el precio en efectivo. Usted es el único responsable de pagar sus recetas en la farmacia autorizada al momento que reciba el servicio, sin embargo, tendrá el derecho a un descuento por parte de la farmacia de acuerdo con el Programa de Tarifas de Descuento que negoció previamente. Towers Administrators LLC (que opera como “SingleCare Administrators”) es la organización autorizada del plan de descuento de recetas médicas ubicada en 4510 Cox Road, Suite 11, Glen Allen, VA 23060. SingleCare Services LLC (“SingleCare”) es la comercializadora del plan de descuento de prescripciones médicas que incluye su sitio web www.singlecare.com. Como información adicional se incluye una lista actualizada de farmacias participantes, así como también asistencia para cualquier problema relacionado con este plan de descuento de prescripciones médicas, comunícate de forma gratuita con el Servicio de Atención al Cliente al 844-234-3057, las 24 horas, los 7 días de la semana (excepto los días festivos). Al utilizar la aplicación o la tarjeta de descuento para recetas médicas de SingleCare acepta todos los Términos y Condiciones, para más información visita: https://www.singlecare.com/es/terminos-y-condiciones. Los nombres, logotipos, marcas y otras marcas comerciales de las farmacias son propiedad exclusiva de sus respectivos dueños.
Los artículos del blog no constituyen asesoramiento médico. Su propósito es brindar información general y no sustituyen el asesoramiento, diagnóstico ni tratamiento médico profesional. Si tiene alguna pregunta sobre una afección médica, consulte siempre a su médico u otro profesional de la salud cualificado. Si cree tener una emergencia médica, llame inmediatamente a su médico o al 911.
© 2026 SingleCare Administrators. Todos los derechos reservados
© 2026 SingleCare Administrators. Todos los derechos reservados